Chronic daily headache

References

• Olesen J, Tfelt-Hansen P, Ramadan N, Goadsby PJ, Welch KMA. The Headaches. Lippincott, Williams & Wilkins, Pennsylvania, PA, USA (2005).
   Google Scholar
• Pascual J, Colas R, Castillo J. Epidemiology of chronic daily headache. Curr. Pain Headache Rep.5(6), 529–536 (2001).
   PubMedGoogle Scholar
• Stovner Lj, Hagen K, Jensen R et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia27(3), 193–210 (2007).
   PubMed Web of Science ®Google Scholar
• Sancisi E, Cevoli S, Pierangeli G et al.. Application of ICHD-II and revised diagnostic criteria to patients with chronic daily headache. Neurol. Sci.28(1), 2–8 (2007).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache43(4), 336–342 (2003).
   PubMed Web of Science ®Google Scholar
• Duru G, Auray JP, Gaudin AF et al. Impact of headache on quality of life in a general population survey in France (GRIM2000 Study). Headache44, 571–580 (2004).
   PubMed Web of Science ®Google Scholar
• Meletiche DM, Lofland JH, Young WB. Quality-of-life differences between patients with episodic and transformed migraine. Headache41(6), 573–578 (2001).
   PubMed Web of Science ®Google Scholar
• Stovner LJ, Hagen K. Prevalence, burden, and cost of headache disorders. Curr. Opin. Neurol.19(3), 281–285 (2006).
   PubMed Web of Science ®Google Scholar
• International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia7(Suppl.), 1–96 (1988).
   Google Scholar
• Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache: comparison to criteria for chronic tension-type headache. Cephalalgia12, 365–368 (1992).
   PubMed Web of Science ®Google Scholar
• Manzoni GC, Granella F, Sandrini G. Classification of chronic daily headache by International Headache Society criteria: limits and new proposal. Cephalalgia15, 37–43 (1995).
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia24(Suppl. 1), 9–160 (2004).
   Google Scholar
• Silberstein SD, Olesen J, Bousser MG et al. The International Classification of Headache Disorders, 2nd edition (ICHD-II) – revision of criteria for 8.2 medication-overuse headache. Cephalalgia25, 460–465 (2005).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB. Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache44, 684–691 (2004).
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia26, 742–746 (2006).
   Google Scholar
• Mathew NT. Transformed or evolutional migraine. Headache27, 305–306 (1987).
   Google Scholar
• Sandrini G, Manzoni GC, Zanferrari C, Nappi G. An epidemiological approach to nosography of chronic daily headache. Cephalalgia13, 72–77 (1993).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA28, 493–494 (2004).
   Google Scholar
• Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache38, 497–506 (1998).
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Schneeweiss S, Kurth T et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology62, 788–790 (2004).
   PubMed Web of Science ®Google Scholar
• Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain106, 81–89 (2003).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology66(4), 545–550 (2006).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology67(2), 252–257 (2006).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache46(9), 1334–1343 (2006).
   PubMed Web of Science ®Google Scholar
• Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology60(8), 1308–1312 (2003).
   PubMed Web of Science ®Google Scholar
• Verri AP, Proietti Cecchini A, Galli C, Granella F, Sandrini G, Nappi G. Psychiatric comorbidity in chronic daily headache. Cephalalgia18(Suppl. 21), 45–49 (1998).
   PubMed Web of Science ®Google Scholar
• Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache40(10), 818–823 (2000).
   PubMed Web of Science ®Google Scholar
• Boes CJ, Capobianco DJ. Chronic migraine and medication-overuse headache through the ages. Cephalalgia25(5), 378–390 (2005).
   PubMed Web of Science ®Google Scholar
• Limmroth V, Katsarava Z, Fritsche G et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology59, 1011–1014 (2002).
   PubMed Web of Science ®Google Scholar
• Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology61(2), 160–164 (2003).
   PubMed Web of Science ®Google Scholar
• Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology62(8), 1338–1342 (2004).
   PubMed Web of Science ®Google Scholar
• Dowson AJ. Analysis of the patients attending a specialist UK headache clinic over a 3-year period. Headache43, 14–18 (2003).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre – clinical characteristics and treatment outcomes. Cephalalgia24(6), 483–490 (2004).
   PubMed Web of Science ®Google Scholar
• Diener HC, Dahlöf CGH. Headache associated with chronic use of substances. In: The Headaches, 2nd Edition. Olesen J, Tfelt-Hansen P, Welch KMA (Eds). Lippincott, Williams & Wilkins, PA, USA, 871–878 (1999).
   Google Scholar
• Meskunas CA, Tepper SJ, Rapoport AM et al. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache46, 766–772 (2006).
   PubMed Web of Science ®Google Scholar
• Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology57, 1694–1698 (2001).
   PubMed Web of Science ®Google Scholar
• Welch KM. Contemporary concepts of migraine pathogenesis. Neurology61(8 Suppl. 4), S2–S8 (2003).
   PubMed Web of Science ®Google Scholar
• Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache4, 629–637 (2001).
   Google Scholar
• Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol.3, 475–483 (2004).
   PubMed Web of Science ®Google Scholar
• Calabresi P, Cupini LM. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol. Sci.26, 62–68 (2005).
   PubMed Web of Science ®Google Scholar
• Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain89(2–3), 107–110 (2001).
   PubMed Web of Science ®Google Scholar
• Ayzenberg I, Obermann M, Nyhuis P et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia26(9), 1106–1114 (2006).
   PubMed Web of Science ®Google Scholar
• Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol. Dis.8, 1–10 (2001).
   PubMed Web of Science ®Google Scholar
• Pini LA, Sandrini M, Vitale G. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur. J. Pharmacol.308(1), 31–40 (1996).
   PubMed Web of Science ®Google Scholar
• Sandrini M, Vitale G, Pini LA. Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes. Pharmacology65, 193–197 (2002).
   PubMed Web of Science ®Google Scholar
• Sandrini M, Pini LA, Vitale G. Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol. Inflamm. Res.52, 347–352 (2003).
   PubMed Web of Science ®Google Scholar
• Dobson CF, Tohyama Y, Diksic M, Hamel E. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia24, 2–11 (2004).
   PubMed Web of Science ®Google Scholar
• Reuter U, Salomone S, Ickenstein GW, Waeber C. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Cephalalgia24, 398–407 (2004).
   PubMed Web of Science ®Google Scholar
• Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc. Natl Acad. Sci. USA96, 7687–7692 (1999).
   PubMed Web of Science ®Google Scholar
• Millan MJ. Descending control of pain. Prog. Neurobiol.66, 355–474 (2002).
   PubMed Web of Science ®Google Scholar
• Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci.25, 319–325 (2002).
   PubMed Web of Science ®Google Scholar
• Fumal A, Laureys S, Di Clemente L et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain129(Pt 2), 543–550 (2006).
   PubMed Web of Science ®Google Scholar
• Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache43, 179–190 (2003).
   PubMed Web of Science ®Google Scholar
• Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache41, 303–309 (2001).
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia25, 12–15 (2005).
   PubMed Web of Science ®Google Scholar
• Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia26, 1192–1198 (2006).
   PubMed Web of Science ®Google Scholar
• Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology66, 1894–1898 (2006).
   PubMed Web of Science ®Google Scholar
• Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet337, 1442–1443 (1991).
   PubMed Web of Science ®Google Scholar
• Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia26, 1097–1105 (2006).
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology57, 1694–1698 (2001).
   PubMed Web of Science ®Google Scholar
• Mathew NT. Amelioration of ergotamine withdrawal with naproxen. Headache27, 130–133 (1987).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia20, 107–113 (2000).
   PubMed Web of Science ®Google Scholar
• Stellar S, Ahrens SP, Meibohm AR et al. Migraine prevention with timolol. A double-blind crossover study. JAMA252, 2576–2580 (1984).
   PubMed Web of Science ®Google Scholar
• Fuller GN, Guiloff RJ. Propanolol in acute migraine: a controlled study. Cephalalgia10, 229–233 (1990).
   PubMed Web of Science ®Google Scholar
• Snow V, Weiss K, Wall EM, Mottur-Pilson C. American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann. Intern. Med.137, 840–849 (2002).
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology55(6), 754–762 (2000).
   PubMed Web of Science ®Google Scholar
• Pascual J, Rivas MT, Leira R. Testing the combination β-blocker plus topiramate in refractory migraine. Acta Neurol. Scand.115(2), 81–83 (2007).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Silva MT, Barbosa JS, Alves LA. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache42, 510–514 (2002).
   PubMed Web of Science ®Google Scholar
• Saper JR, Silberstein SD, Lake AE 3rd, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache34, 497–502 (1994).
   PubMed Web of Science ®Google Scholar
• Coward DM. Tizanidine: neuropharmacology and mechanism of action. Neurology44(11 Suppl. 9), S6–S10 (1994).
   PubMed Web of Science ®Google Scholar
• Saper JR, Winner PK, Lake AE 3rd. An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache. Headache41(4), 357–368 (2001).
   PubMed Web of Science ®Google Scholar
• Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache42, 470–482 (2002).
   PubMed Web of Science ®Google Scholar
• Spira PJ, Beran RG; Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology61, 1753–1759 (2003).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache31, 71–74 (1991).
   PubMed Web of Science ®Google Scholar
• Freitag FG, Diamond S, Diamond ML, Urban GJ. Divalproex in the long-term treatment of chronic daily headache. Headache41, 271–278 (2001).
   PubMed Web of Science ®Google Scholar
• Brandes JL, Saper JR, Diamond M et al. MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA291, 965–973 (2004).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch. Neurol.61, 490–495 (2004).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Lipton RB, Dodick DW et al. Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache47(2), 170–180 (2007).
   PubMed Web of Science ®Google Scholar
• Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia27(7), 814–823 (2007).
   PubMed Web of Science ®Google Scholar
• Limmroth V, Biondi D, Pfeil J, Schwalen S. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. Headache47(1), 13–21 (2007).
   PubMed Web of Science ®Google Scholar
• Aoki KR. Evidence for antinociceptive activity of botulinum toxin type-A in pain management. Headache43(Suppl. 1), S9–S15 (2003).
   PubMed Web of Science ®Google Scholar
• Durham PL, Cady R, Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache44, 35–43 (2004).
   PubMed Web of Science ®Google Scholar
• Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache40(6), 445–450 (2000).
   PubMed Web of Science ®Google Scholar
• Anand KS, Prasad A, Singh MM, Sharma S, Bala K. Botulinum toxin type A in prophylactic treatment of migraine. Am. J. Ther.13(3), 183–187 (2006).
   PubMedGoogle Scholar
• Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C. European BoNTA Headache Study Group. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. Cephalalgia27(6), 492–503 (2007).
   PubMed Web of Science ®Google Scholar
• Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM; BOTOX North American Episodic Migraine Study Group. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Headache47(4), 486–499 (2007).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Stark SR, Lucas SM, Christie SN, Degryse RE, Turkel CC; BoNTA-039 Study Group. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin. Proc.80(9), 1126–1137 (2005).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Frishberg BM, Gawel M et al.. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache45, 293–307 (2005).
   PubMed Web of Science ®Google Scholar
• Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population: a prevalence study. J. Clin. Epidemiol.44, 1147–1157 (1991).
   PubMed Web of Science ®Google Scholar
• Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA279, 381–383 (1998).
   PubMed Web of Science ®Google Scholar
• Rasmussen BK, Lipton RB. Epidemiology of tension-type headache. In: The Headaches (2nd Edition). Olesen J, Tfelt-Hansen P, Welch KMA (Eds). Lippincott, Williams & Wilkins, PA, USA, 545–550 (2000).
   Google Scholar
• Jensen R, Symon D. Epidemiology of tension-type headaches. In: The Headaches (3rd Edition). Olesen J, Goadsby PJ, Ramadan N et al. (Eds). Lippincott, Williams & Wilkins, PA, USA, 621–624 (2005).
   Google Scholar
• Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur. J. Epidemiol.20, 243–249 (2005).
   PubMed Web of Science ®Google Scholar
• Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J. Occup. Environ. Med.39, 320–327 (1997).
   PubMed Web of Science ®Google Scholar
• Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Incidence of primary headache: a Danish epidemiologic follow-up study. Am. J. Epidemiol.161, 1066–1073 (2005).
   PubMed Web of Science ®Google Scholar
• Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Prognosis of migraine and tension-type headache: a population-based follow-up study. Neurology65, 580–585 (2005).
   PubMed Web of Science ®Google Scholar
• Jensen R, Becker WJ. Symptomatology of tension-type headaches. In: The Headaches (3rd Edition). Olesen J, Goadsby PJ, Ramadan N et al. (Eds). Lippincott, Williams & Wilkins, PA, USA, 655–692 (2005).
   Google Scholar
• Peatfield RC, Edmeads JG. General approach to treatment of tension-type headaches. In: The Headaches (3rd Edition). Olesen J, Goadsby PJ, Ramadan N et al. (Eds). Lippincott, Williams & Wilkins, PA, USA, 707–710 (2005).
   Google Scholar
• Janke EA, Holroyd KA, Romanek K. Depression increases onset of tension-type headache following laboratory stress. Pain111, 230–238 (2004).
   PubMed Web of Science ®Google Scholar
• Ashina S, Bendtsen L, Ashina M. Pathophysiology of tension-type headache. Curr. Pain Headache Rep.9, 415–422 (2005).
   PubMedGoogle Scholar
• Bendtsen L, Schoenen J. Synthesis of tension-type headache mechanisms. In: The Headaches (3rd Edition). Olesen J, Goadsby PJ, Ramadan N et al. (Eds). Lippincott, Williams & Wilkins, PA, USA, 677–681 (2005).
   Google Scholar
• Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain118(1–2), 215–223 (2005).
   PubMed Web of Science ®Google Scholar
• Schmidt-Wilcke T, Leinisch E, Straube A, et al. Gray matter decrease in patients with chronic tension type headache. Neurology65, 1483–1486 (2005).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Bendtsen L. Prophylactic pharmacotherapy of tension-type headache. In: The Headaches, 2nd Edition. Olesen J, Tfelt-Hansen P, Welch KMA (Eds). Lippincott, Williams & Wilkins, PA, USA, 667–774 (2000).
   Google Scholar
• Holroyd KA, Martin PR. Psychological treatments for tension-type headache In: The Headaches (2nd Edition). Olesen J, Tfelt-Hansen P, Welch KMA (Eds). Lippincott, Williams & Wilkins, PA, USA, 643–649 (2000).
   Google Scholar
• Biondi DM. Physical treatments for headache: a structured review. Headache45, 738–746 (2005).
   PubMed Web of Science ®Google Scholar
• Lenssinck ML, Damen L, Verhagen AP et al. The effectiveness of physiotherapy and manipulation in patients with tension-type headache: a systematic review. Pain112, 381–388 (2004).
   PubMed Web of Science ®Google Scholar
• Holroyd KA, O’Donnell FJ, Stensland M et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress-management therapy, and their combination: a randomized controlled trial. JAMA285, 2208–2215 (2001).
   PubMed Web of Science ®Google Scholar
• Leinisch-Dahlke E, Jurgens T, Bogdahn U et al. Greater occipital nerve block is ineffective in chronic tension-type headache. Cephalalgia25, 704–708 (2005).
   PubMed Web of Science ®Google Scholar
• Melchart D, Streng A, Hoppe A et al. Acupuncture in patients with tension-type headache: randomised controlled trial. Br. Med. J.331, 376–382 (2005).
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram) serotonin reuptake inhibitor is effective in the treatment of chronic tension-type headache. J. Neurol. Neurosurg. Psychiatr.61, 285–290 (1996).
   PubMed Web of Science ®Google Scholar
• Boz C, Altunayoglu V, Velioglu S, Ozmenoglu M. Sertraline versus amitriptyline in the prophylactic therapy of non-depressed chronic tension-type headache patients. Headache4, 72–78 (2002).
   Google Scholar
• Ashina S, Bendtsen L, Jensen R. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition. Pain108, 108–114 (2004).
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia20, 603–610 (2000).
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology62, 1706–1711 (2004)
   PubMed Web of Science ®Google Scholar
• Singh NN, Misra S. Sertraline in chronic tension-type headache. J. Assoc. Physicians India50, 873–878 (2002)
   PubMedGoogle Scholar
• Silberstein SD, Gobel H, Jensen R et al. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia26(7), 790–800 (2006).
   PubMed Web of Science ®Google Scholar
• Padberg M, de Bruijn SF, de Haan RJ, Tavy DL. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia24, 675–680 (2004).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Göbel H, Jensen R et al. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia26(7), 790–800 (2006).
   PubMed Web of Science ®Google Scholar
• Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD. BOTOX CDH Study Group. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache45(4), 315–324 (2005).
   PubMed Web of Science ®Google Scholar
• Rasmussen BK, Jensen R, Schroll M, Olesen J. Impact of headache in a general population: a prevalence study. J. Clin. Epidemiol.44, 1147–1157 (1991).
   PubMed Web of Science ®Google Scholar
• Ward TN. Medication overuse headache. Prim. Care31, 369–380 (2004)
   PubMed Web of Science ®Google Scholar
• Mathew N. Tension-type headache. Curr. Neurol. Neurosci. Rep.6, 100–105 (2006).
   PubMed Web of Science ®Google Scholar
• Jensen R. Diagnosis, epidemiology and impact of tension-type headache. Curr. Pain Headache Rep.7, 455–459 (2003).
   PubMedGoogle Scholar
• Eisenberg DM, Kessler RC, Van Rompay MI et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann. Intern. Med.135, 344–351 (2001).
   PubMed Web of Science ®Google Scholar
• Long L, Huntley, A, Ernst E. Which complementary and alternative therapies benefit which conditions? A survey of the opinions of 223 professional organizations. Complement. Ther. Med.9, 178–185 (2001)
   PubMed Web of Science ®Google Scholar
• Rossi P, Di Lorenzo G, Faroni J, Malpezzi MG, Cesarino F, Nappi G. Use of complementary and alternative medicine by patients with chronic tension-type headache: results of a headache clinic survey. Headache46, 622–631 (2006).
   PubMed Web of Science ®Google Scholar
• Nash JM, Willliams DM, Nicholson R, Trask PC. The contribution of pain-related anxiety to disability from headache. J. Behav. Med.29, 61–67 (2006).
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Jensen R. Tension-type headache. The most common, but also the most neglected, headache disorder. Curr. Opin. Neurol.19, 305–309 (2006).
   PubMed Web of Science ®Google Scholar
• Fernandez-de-las-Penas C, Alonso-Blanco C, Cuadrado ML, Gerwin RD, Pareja JA. Trigger points in the suboccipital muscles and forward head posture in tension-type headache. Headache46, 454–460 (2006).
   PubMed Web of Science ®Google Scholar
• Lenssinck ML, Damen L, Verhagen AP, Berger MY, Passchier J, Koes BW. The effectiveness of physiotherapy and manipulation in patients with tension-type headache: a systematic review. Pain112, 381–386 (2004).
   PubMed Web of Science ®Google Scholar
• Bromfort G, Nilsson N, Haas M et al. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst. Rev.CD001878 (2004).
   Google Scholar
• Torelli P, Jensen R, Olesen J. Physiotherapy for tension-type headache: a controlled study. Cephalalgia24, 29–37 (2004).
   PubMed Web of Science ®Google Scholar
• Van Ettekoven H, Lucas C. Efficacy of physiotherapy including a craniocervical training programme for tension-type headache: a randomized clinical trial. Cephalalgia26, 983–991 (2006).
   PubMed Web of Science ®Google Scholar
• Soderberg E, Carlsson J, Stener-Victorin E. Chronic tension-type headache treated with acupuncture, physical training and relaxation training. Between-group differences. Cephalalgia26, 1320–1329 (2006).
   PubMed Web of Science ®Google Scholar
• Melchart D, Linde K, Fischer P et al. Acupuncture for idiopathic headache. Cochrane Database Syst. Rev.CD001218 (2001).
   Google Scholar
• Xue CC, Dong L, Polus B et al. Electroacupuncture for tension-type headache on distal acupoints only : a randomized controlled crossover trial. Headache44, 333–341 (2004).
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Rees RW, Zollman CE et al. Acupuncture for chronic headache disorders in primary care: large pragmatic randomized trial. Br. Med. J.3, 1–6 (2004).
   Google Scholar
• Melchart D, Weidenhammer W, Streng A, Hoppe A, Pfaffenrath V, Linde K. Acupuncture for chronic headaches: an epidemiological study. Headache46, 632–641 (2006)
   PubMed Web of Science ®Google Scholar
• Karst M, Rehnard M, Thum P, Wiese B, Rollnik J, Fink M. Needle acupuncture in tension-type headache: a randomized placebo controlled study. Cephalalgia21(Suppl. 6), 637–642 (2001).
   PubMed Web of Science ®Google Scholar
• Cummings M. No difference between acupuncture and sham in chronic tension-type headache. Acupunct. Med.19, 51–53 (2001).
   PubMedGoogle Scholar
• Astin JA, Ernst E. The effectiveness of spinal manipulation for the treatment of headache disorders: a systematic review of randomized clinical trials. Cephalalgia22, 617–623 (2002).
   PubMed Web of Science ®Google Scholar
• Ernst E. Manual therapies for pain control: chiropractic and massage. Clin. J. Pain.20, 8–12 (2004).
   PubMed Web of Science ®Google Scholar
• Fernandez-de-las-Penas C, Alonso-Blanco C, Cuadrado ML, Miangolarra JC, Barriga FJ, Pareja JA. Are manual therapies effective in reducing pain from tension-type headache ? A systematic review. Clin. J. Pain22, 278–285 (2006).
   PubMed Web of Science ®Google Scholar
• Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Appl. Psychophysiol. Biofeedback27, 163–181 (2002).
   PubMed Web of Science ®Google Scholar
• Rains JC, Penzien DB, McCrory DC, Gray RN. Behavioral headache treatment: history, review of the empirical literature and methodological critique. Headache45(Suppl. 2), S92–S109 (2005).
   PubMed Web of Science ®Google Scholar
• McCrory DC, Penzien DB, Hasselblad V, Gray RN, for the Duke University Evidence-based Practice Center, Center for Clinical Health Policy Research, Foundation for Chiropractic Education and Research. Evidence Report: Behavioral and Physical Treatments for Tension-type and Cervicogenic Headache. Foundation for Chiropractic Education and Research, Des Moines, IA, USA (2001).
   Google Scholar
• Bogaards EB, ter Kuile MM. Treatment of recurrent tension-type headache: a meta-analytic review. Clin. J. Pain10, 174–190 (1994).
   PubMed Web of Science ®Google Scholar
• Haddock CK, Rowan AB, Andrasik F, Wilson PG, Talcott GW, Stein RJ. Home-based behavioural treatments for chronic benign headache: a meta-analysis of controlled trials. Cephalalgia17, 113–118 (1997).
   PubMed Web of Science ®Google Scholar
• Devineni T, Blanchard EB. A randomized controlled trial of an internet-based treatment for chronic headache. Behav. Res. Ther.43, 277–292 (2005).
   PubMed Web of Science ®Google Scholar
• Trautmann E, Lackshewitz H, Kroner-Herwig B. Psychological treatment of recurrent headache in children and adolescents. Cephalalgia26, 1411–1426 (2006).
   PubMed Web of Science ®Google Scholar
• Sjastaad O, Spierings EL. “Hemicrania continua”. Another headache absolutely responsive to indomethacin. Cephalalgia4, 65–70 (1984).
   PubMed Web of Science ®Google Scholar
• Peres MF, Silberstein SD, Nahmias S et al. Hemicrania continua is not that rare. Neurology57, 948–951 (2001).
   PubMed Web of Science ®Google Scholar
• Sjastaad O, Bakketeig LS. The rare, unilateral headaches. Vaga study of headache epidemiology. J. Headache Pain8, 19–27 (2007).
   PubMedGoogle Scholar
• Pareja J, Vincent M, Antonaci F, Sjaastad O. Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia21, 874–877 (2001).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain120, 193–209 (1997).
   PubMed Web of Science ®Google Scholar
• Matharu MS, Cohen AS, McGonigle DJ, Ward N, Frackowiak, RS, Goadsby PJ. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache44, 747–761 (2004).
   PubMed Web of Science ®Google Scholar
• Spierings ELH, Sjaastad O. Hamicrania continua is not that rare. Neurology59, 476 (2002).
   PubMedGoogle Scholar
• Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua. Parenteral indomethacin: the “Indotest”. Headache8, 235–236 (1998).
   Google Scholar
• Pareja JA, Caminero AB, Franco E, Casado JL, Pascual J, Sanchez del Rio M. Dose, efficacy and tolerability of long-term indomethacin reatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia21, 906–910 (2001).
   PubMed Web of Science ®Google Scholar
• Dodick D. Indomethacin-responsive headache syndromes. Curr. Pain Headache Rep.8, 19–26 (2004).
   PubMedGoogle Scholar
• Sjaastad O. Chonic paroxysmal hemicrania, hemicrania continua and SUNCT: the fate of the first three described cases. J. Headache Pain7, 151–156 (2006).
   PubMedGoogle Scholar
• Sjaastad O, Antonaci F. A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. Headache35, 549–550 (1995).
   PubMed Web of Science ®Google Scholar
• Peres MF, Silberstein SD. Hemicrania continua responds to cyclooxygenase-2 inhibitors. Headache42, 530–531 (2002).
   PubMed Web of Science ®Google Scholar
• Peres MF, Zuckerman E. Hemicrania continua responsive to rofecoxib. Cephalalgia20, 130–131 (2000).
   PubMed Web of Science ®Google Scholar
• Lenzer J. FDA advisers warn: COX2-inhibitors increased risk of heart attack and stroke. Br. Med. J.330, 440 (2005).
   PubMed Web of Science ®Google Scholar
• Rozen TD. Melatonin responsive hemicrania continua. Headache46, 1203–1208 (2006).
   PubMed Web of Science ®Google Scholar
• Spears RC. Hemicrania continua: a case in which a patient experienced complete relief on melatonin. Headache46, 524–527 (2006).
   PubMed Web of Science ®Google Scholar
• Matharu MS, Bradbury P, Swash M. Hemicrania continua: side alternation and response to topiramate. Cephalalgia26, 341–344 (2005).
   Web of Science ®Google Scholar
• Brighina F, Palermo A,Cosentino G, Fierro B. Prophylaxis of hemicrania continua: two new cases effectively treated with topiramate. Headache47, 441–443 (2007).
   PubMed Web of Science ®Google Scholar
• Matharu MS, Boes CJ, Goadsby PJ. Management of trigeminal autonomic cephalalgias and hemicrania continua. Drugs63, 1637–1677 (2003).
   PubMed Web of Science ®Google Scholar
• Rajabally YA, Jacob S. Hemicrania continua responsive to verapamil. Headache45, 1082–1087 (2005).
   PubMed Web of Science ®Google Scholar
• Antonaci F, Pareva JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: lack of efficacy of sumatriptan. Headache38, 197–200 (1996).
   Web of Science ®Google Scholar
• Bordini C, Antonaci F, Stovner LJ, Schrader H, Sjaastad O. “Hemicrania continua”: a clinical review. Headache31, 20–26 (1991).
   PubMed Web of Science ®Google Scholar
• Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: anaesthetic blockades of pericranial nerves. Funct. Neurol.1, 11–15 (1997).
   Google Scholar
• Schwedt TJ, Dodick DW, Hentz J, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic headache – long term safety and efficacy. Cephalalgia27, 153–157 (2007).
   PubMed Web of Science ®Google Scholar
• Rossi P, Faroni V, Tassorelli C, Nappi G. Diagnostic delays and mismanagement of hemicrania continua. Cephalalgia6, 700 (2007).
   Google Scholar
• Pareja JA, Antonaci F, Vincent M. The hemicrania continua diagnosis. Cephalalgia21, 940–946 (2001).
   PubMed Web of Science ®Google Scholar
• Diaz-Mitorna F, Vanast WJ, Tirrel DLJ. Increased frequency of Epstein–Barr virus excretion in patients with new-daily persistent headache. Lancet1, 411–415 (1987).
   PubMed Web of Science ®Google Scholar
• Vanast WJ. New daily persistent headache: definition of a benign syndrome. Headache26, 317 (1986).
   Google Scholar
• Li D, Rozen TD. The clinical characteristics of new daily-persistent headache. Cephalalgia22, 66–69 (2002).
   PubMed Web of Science ®Google Scholar
• Rozen T, Swidan SZ. Elevation of CSF tumor necrosis factor a levels in new daily-persistent headache and treatment refractory chronic migraine. Headache47, 1050–1052 (2007).
   PubMed Web of Science ®Google Scholar
• Rozen TD, Roth JM, Denenberg N. Cervical spine joint hypermobility: a possible predisposing factor for new daily-persistent headache. Cephalalgia26, 1182–1185 (2006).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Boes C. New daily persistent headache. J. Neurol. Neurosurg. Psychiatr.72(Suppl. II), ii6–ii9 (2002).
   PubMedGoogle Scholar
• Takase Y, Nakano M, Tatsumi C, Matsuyama T. Clinical features, effectiveness of drug-based treatment, and prognosis of new daily-persistent headache (NDPH): 30 cases in Japan. Cephalalgia24(11), 955–959 (2004).
   PubMed Web of Science ®Google Scholar
• Meineri P, Torre E, Rota E, Grasso E. New daily-persistent headache: clinical and serological characteristics in a retrospective study. Neurol. Sci.25, S281–S282 (2004).
   PubMed Web of Science ®Google Scholar
• Evans RW, Rozen TD. Etiology and treatment of new daily persistent headache. Headache41, 830–832 (2001).
   PubMed Web of Science ®Google Scholar
• Sjaastad O. “Chronic daily headache” (“cefalea cronica quotidiana”). Cephalalgia5(Suppl. 2), 191–193 (1985).
   PubMed Web of Science ®Google Scholar
• Nappi G, Savoldi F. Headache: Diagnostic System and Taxonomic Criteria. Libbey J (Ed.). John Libbey Eurotext, London (1985).
   Google Scholar
• Sandrini G, Cecchini AP, Tassorelli C, Nappi G. Diagnostic issues in chronic daily headache. Curr. Pain Headache Rep.5(6), 551–556 (2001).
   PubMedGoogle Scholar
• Popeney CA, Aló KM. Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache43(4), 369–375 (2003).
   PubMed Web of Science ®Google Scholar
• Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain127, 220–230 (2004).
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Dodick DW. Occipital nerve stimulation for TACs: pain relief and persistence of autonomic features. Cephalagia26, 1025–1027 (2006).
   PubMed Web of Science ®Google Scholar
• Schoenen J, Di Clemente L, Vandenheede M et al. Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain128, 940–947 (2005).
   PubMed Web of Science ®Google Scholar
• Leone M, Franzini A, D’Andrea G, Broggi G, Casucci G, Bussone G. Deep brain stimulation to relieve drug-resistant SUNCT. Ann. Neurol.57, 924–927 (2005).
   PubMed Web of Science ®Google Scholar
• Leone M, May A, Franzini A et al. Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia24, 934–937 (2004).
   PubMed Web of Science ®Google Scholar